The crosstalk between benign thyroid disease and breast cancer: A single center study

Yajuan Zheng,Hongchao Tang,Jun Wu,Dandan Guan,Qiuping Mo,Qinghui Zheng
DOI: https://doi.org/10.1097/md.0000000000037298
IF: 1.6
2024-03-09
Medicine
Abstract:This study aims to carry out research on the association between breast cancer and thyroid diseases. Breast cancer, the most prevalent malignant tumor among women worldwide, is renowned for its high occurrence and mortality rates. [ 1 , 2 ] Currently, breast cancer is categorized into 4 different pathological types: in situ cancer, early-stage invasive cancer, specialized invasive cancer, and nonspecific invasive cancer. With continuous advancements in early detection and clinical treatment strategies, the 5-year survival rate for breast cancer has significantly increased. [ 3 , 4 ] However, it is important to acknowledge that breast cancer remains a significant cause of mortality for women, with the second highest mortality rate among female cancers. In 2022, there were more than 2260,000 new cases of breast cancer diagnosed worldwide, resulting in over 500,000 reported deaths. [ 5 ] The main reason why breast cancer leads to death is the recurrence of cancer. The primary cause of recurrence is the spread of breast cancer cells, with triple-negative breast cancer cells being an aggressive and difficult-to-treat type of breast cancer associated with a poor prognosis. [ 6–8 ] Different changes in key genes and pathways are involved in the metastasis process of various types of breast cancer cell lines. Furthermore, deaths reported in previous studies can be attributed to drug resistance and breast cancer subtypes. [ 6 , 9 , 10 ] Some studies suggest that benign thyroid disease may be involved in the progression of breast cancer. [ 7 ] Related information remains limit.
medicine, general & internal
What problem does this paper attempt to address?